Suppr超能文献

口服抗凝治疗患者血浆中凝血酶原转化的抑制剂。

The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.

作者信息

Bertina R M, Westhoek-Kuipers M E, Alderkamp G H

出版信息

Thromb Haemost. 1981 Jun 30;45(3):237-41.

PMID:7281102
Abstract

Pooled plasma of patients under stable oral anticoagulation has been analysed with respect to the presence of the vitamin-K dependent factors (factors II, VII, IX and X). Of all factors 1.5-2 times more antigen than procoagulant activity was present. The concentration of factors II, X (measured spectrophotometrically) and VI is about 0.25 U/ml while factor IX is slightly higher. Coagulation assays of factor X always gave lower values than the spectrophotometric assay. This discrepancy was not influenced by the removal of either factor II-, factor VII- or factor IX antigen. However, when the factor X antigen was replaced by normal factor X, all factor X assay gave identical results, indicating that PIVKA X is responsible for these discrepancies. Using the technic of the Thrombotest-dilution curve it was shown that PIVKA X is the factor that causes the abnormal prolongation of ox-brain prothrombin time in these plasmas.

摘要

已对接受稳定口服抗凝治疗患者的混合血浆进行分析,以检测维生素K依赖性因子(因子II、VII、IX和X)的存在情况。在所有因子中,抗原含量比促凝血活性高1.5至2倍。因子II、X(通过分光光度法测量)和VII的浓度约为0.25 U/ml,而因子IX略高。因子X的凝血测定值总是低于分光光度法测定值。去除因子II、因子VII或因子IX抗原均不影响这种差异。然而,当用正常因子X替代因子X抗原时,所有因子X测定结果相同,表明异常凝血酶原X(PIVKA X)是造成这些差异的原因。采用凝血酶检测稀释曲线技术表明,PIVKA X是导致这些血浆中牛脑凝血酶原时间异常延长的因子。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验